ArticleAnnals of medicine and surgery (2012)2026
Mepitel Film or StrataXRT for postmastectomy radiation dermatitis: current evidence and implications.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute radiation dermatitis (ARD) is a frequent adverse effect following postmastectomy radiotherapy. Barrier dressings such as Mepitel Film and StrataXRT are increasingly used to prevent or reduce its severity, yet comparative data remain limited. Recent studies, mostly single-center or intra-patient in design with small sample sizes, have demonstrated the effectiveness of both in protection against skin toxicity, although larger multicenter validation is still needed. Within the current evidence base, StrataXRT showed advantages in tolerability, comfort, and application convenience, whereas Mepitel Film use offered slightly greater efficacy against ARD. This letter reviews emerging evidence comparing these two interventions, emphasizing their practical implications for clinical decision-making and future research priorities in ARD prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.